Effect of Pretransplant Use of Calcimimetic on Parathyroid Function after Renal Transplantation

Table 4

Predictors for persistent hyperparathyroidism.

Characteristic	Odds ratio (95% CI)	value
Age
<51 y	Reference	—
≥51 y	1.3 (0.5–3.8)	0.5526
Duration of dialysis pretransplantation
<3 y	Reference	—
≥3 y	5.1(1.7–15.2)	0.0033
PTH before
<215 ng/mL	Reference	—
≥215 ng/mL	1.2 (0.4–3.3)	0.7581

Persistent hyperparathyroidism includes hyperparathyroidism which needed either medication of calcimimetic, vitamin D, bisphosphonate, denosumab, and/or parathyroidectomy after renal transplantation. Bold values are those found to be significant; value < 0.05. RT, renal transplantation; PTH, parathyroid hormone.